IT7927064A0 - Composizione di mucopolisaccaride avente un'azione regolatrice della coagulazione, medicamento contenente tale composizione eprocedimento per prepararla. - Google Patents

Composizione di mucopolisaccaride avente un'azione regolatrice della coagulazione, medicamento contenente tale composizione eprocedimento per prepararla.

Info

Publication number
IT7927064A0
IT7927064A0 IT7927064A IT2706479A IT7927064A0 IT 7927064 A0 IT7927064 A0 IT 7927064A0 IT 7927064 A IT7927064 A IT 7927064A IT 2706479 A IT2706479 A IT 2706479A IT 7927064 A0 IT7927064 A0 IT 7927064A0
Authority
IT
Italy
Prior art keywords
composition
mucopolysaccharide
preparing
procedure
product containing
Prior art date
Application number
IT7927064A
Other languages
English (en)
Other versions
IT1126319B (it
Inventor
Lormeau Jean Claude
Goulay Jean
Choay Jean
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7831357A external-priority patent/FR2440376A1/fr
Priority claimed from FR7918873A external-priority patent/FR2461719A2/fr
Application filed by Choay Sa filed Critical Choay Sa
Publication of IT7927064A0 publication Critical patent/IT7927064A0/it
Application granted granted Critical
Publication of IT1126319B publication Critical patent/IT1126319B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121—Serpins
    • G01N2333/8128—Antithrombin III
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IT27064/79A 1978-11-06 1979-11-06 Composizione di mucopolisaccaride avente un'azione regolatrice della coagulazione,medicamento contenente tale composizione e procedimento per prepararla IT1126319B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7831357A FR2440376A1 (fr) 1978-11-06 1978-11-06 Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
FR7918873A FR2461719A2 (fr) 1979-07-20 1979-07-20 Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir

Publications (2)

Publication Number Publication Date
IT7927064A0 true IT7927064A0 (it) 1979-11-06
IT1126319B IT1126319B (it) 1986-05-21

Family

ID=26220837

Family Applications (1)

Application Number Title Priority Date Filing Date
IT27064/79A IT1126319B (it) 1978-11-06 1979-11-06 Composizione di mucopolisaccaride avente un'azione regolatrice della coagulazione,medicamento contenente tale composizione e procedimento per prepararla

Country Status (6)

Country Link
US (1) US4486420A (it)
JP (1) JPH03243601A (it)
DE (1) DE2944792C3 (it)
GB (1) GB2035349B (it)
IT (1) IT1126319B (it)
SE (1) SE449753B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692435A (en) * 1978-11-06 1987-09-08 Choay, S.A. Mucopolysaccharide composition having a regulatory action on coagulation, medicament containing same and process of preparation
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
IT1163772B (it) * 1983-07-13 1987-04-08 Baldacci Lab Spa Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche
FR2568774B2 (fr) * 1984-05-30 1989-05-19 Choay Sa Medicaments favorisant les proprietes d'ecoulement du sang et leur utilisation en therapeutique
CA1260461A (fr) * 1984-10-18 1989-09-26 Jean-Claude Lormeau Procede de preparation de compositions de mucopolysaccharides dotes d'une activite antithrombotique elevee
US4788307A (en) * 1986-04-30 1988-11-29 Choay S.A. Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity
US4942156A (en) * 1986-08-20 1990-07-17 Hepar Industries, Inc. Low molecular weight heparin derivatives having improved anti-Xa specificity
US4745106A (en) * 1986-08-20 1988-05-17 Griffin Charles C Heparin derivatives having improved anti-Xa specificity
USRE38743E1 (en) 1990-06-26 2005-06-14 Aventis Pharma S.A. Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
DE69731763T3 (de) * 1996-11-27 2010-12-30 Aventis Pharmaceuticals Inc. Pharmazeutische Zusammenstellung, die eine Verbindung mit Anti-Xa-Eigenschaften und eine Verbindung, die ein Plakettenaggregationsantagonist ist, enthalten
US6075013A (en) * 1997-06-06 2000-06-13 Hamilton Civic Hospitals Research Development Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors
WO2000065521A2 (en) 1999-04-23 2000-11-02 Massachusetts Institute Of Technology System and method for polymer notation
HUP0201712A3 (en) * 1999-06-30 2003-03-28 Weitz Jeffrey I Ancaster Clot associated coagulation factors inhibiting heparin compositions
AU2001291549A1 (en) * 2000-09-08 2002-03-22 Hamilton Civic Hospitals Research Development Inc. Antithrombotic compositions
EP2283045A1 (en) * 2008-05-20 2011-02-16 Crystal Clear Partnership Separation of polysaccharides by charge density gradient

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1042001A (en) * 1973-04-13 1978-11-07 Choay S.A. Mixed heparin salts
SE431218B (sv) * 1976-03-05 1984-01-23 Kabi Ab Forfarande for rening av heparin
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
US4122250A (en) * 1977-08-22 1978-10-24 Gottfried Schmer Separation of high-activity heparin by affinity chromatography
US4175182A (en) * 1978-07-03 1979-11-20 Research Corporation Separation of high-activity heparin by affinity chromatography on supported protamine
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
HU177887B (en) * 1979-03-21 1982-01-28 Richter Gedeon Vegyeszet Process for preparing a raw material containing heparin
US4281108A (en) * 1980-01-28 1981-07-28 Hepar Industries, Inc. Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained

Also Published As

Publication number Publication date
GB2035349A (en) 1980-06-18
JPH03243601A (ja) 1991-10-30
SE7909087L (sv) 1980-05-07
DE2944792A1 (de) 1980-05-14
DE2944792C2 (it) 1994-04-14
GB2035349B (en) 1983-05-11
DE2944792C3 (de) 1994-04-14
US4486420A (en) 1984-12-04
IT1126319B (it) 1986-05-21
SE449753B (sv) 1987-05-18

Similar Documents

Publication Publication Date Title
IT7927064A0 (it) Composizione di mucopolisaccaride avente un'azione regolatrice della coagulazione, medicamento contenente tale composizione eprocedimento per prepararla.
PH19749A (en) New optically active 1,4-dihydro-pyridine compounds,their production and their medicinal use
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
NZ191462A (en) Derivatives of 2 ,16 -bis-piperidino-3 -hydroxy-5 -androstane-3 -esters
EP0006614A3 (en) Pyridyl- and imidazopyridyloxypropanolamines, process for preparing the same and pharmaceutical compositions containing the same
IT1193847B (it) Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline
NO152414C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider
GR60791B (en) 2',3',6'-trichlor-4-cyano-4'-benzoylureido-diphenylether,preparation process and use thereof as insecticides
DE2962943D1 (en) Process for the preparation of 2,6-dialkyl-n-alkylanilines
IT1123137B (it) "3",4"-diaciltilosina e procedimento per la sua produzione
GB2036019B (en) Preparing n,n'-diaryl-p-phenylenediamines
DE2960770D1 (en) Process for the preparation of 2,2,4-trimethyl-3-hydroxypentyl-isobutyrate
ZA792042B (en) Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
RO76486A (ro) Procedeu pentru prepararea unor 2,6-dinitrobenzenamine
IL58677A (en) Preparation of 1 alpha,3 beta-dihydroxy-delta 5-steroids and some such novel compounds
ZA784842B (en) New 3,4,5-trihydroxypiperidine compounds,their production and their medicinal use
IL57649A0 (en) Derivatives of 3-azabicycl(3.1.0)hexane and their preparation
DE2960507D1 (en) Process for the preparation of 4,4'-diaminobenzhydrol and its substitution products
IT1123731B (it) Procedimento per la preparazione di 1,2,3-tiadiazol-5-il-uree
DE2962366D1 (en) Process for the preparation of 2,3-dihydro-2,2-dimethyl-7-hydroxy-benzofurane
GB2014147B (en) Production of 1,3-diaza-heterocycles
SU687097A1 (ru) Состав дл обмеловки текстильного материала

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 418

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 418, 19921229; CHOAY S.A.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971128